Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,836.27 +2,098.18 (+3.24%) CMC Crypto 200
1,366.45 -7.39 (-0.54%)
CDXS May 2024 5.000 call
| Previous close | 0.0800 |
| Open | 0.0800 |
| Bid | 0.0000 |
| Ask | 0.0500 |
| Strike | 5.00 |
| Expiry date | 2024-05-17 |
| Day's range | 0.0800 - 0.0800 |
| Contract range | N/A |
| Volume | |
| Open interest | 95 |
GlobeNewswireCodexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
REDWOOD CITY, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has successfully synthesized an oligonucleotide via an enzymatic route to support RNA-based therapeutics manufacturing. Data highlighting this historic manufacturing milestone are being presented today in a Spotlight Presentation at the TIDES USA annual meeting taking place in Boston, MA, and virtually May 14 – 17, 2024. “The data presented today by Codexi
Simply Wall St.Codexis First Quarter 2024 Earnings: Beats Expectations
Codexis ( NASDAQ:CDXS ) First Quarter 2024 Results Key Financial Results Revenue: US$17.1m (up 32% from 1Q 2023). Net...
Insider MonkeyCodexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript
Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript May 2, 2024 Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1647, expectations were $-0.17. Codexis, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Codexis’ First Quarter 2024 […]
